Psoriasis affects around two in every hundred people in the UK, yet it is still widely misunderstood. Many people assume it is simply dry skin, but it is actually a condition linked to the immune system.
When someone has psoriasis, their skin cells are made much faster than normal. Skin usually renews itself every three to four weeks. For someone with psoriasis, this can happen in as little as three to seven days. The skin cells build up on the surface before they are ready, causing the raised, flaky patches most people recognize as psoriasis.
These patches can look pink or red on white skin, and darker or purple on brown and black skin. They often appear on the elbows, knees, scalp and lower back, though psoriasis can turn up almost anywhere on the body, including the nails.
Doctors do not fully understand what triggers psoriasis to develop. Genetics plays a part. If a close family member has it, a person is more likely to develop it too. But having the genes does not guarantee it will appear. Things like stress, skin injuries, certain infections and some medicines can set off a flare-up in people who are already prone to the condition.
One of the most frustrating things about psoriasis is that it comes and goes. Someone might have clear skin for months, then experience a flare-up that lasts weeks. This unpredictability, combined with the visible nature of the condition, can affect confidence as much as physical comfort.
There is currently no cure for psoriasis, but treatment has come a long way. Creams and ointments can calm mild cases, while light therapy and stronger medicines help people with more severe symptoms. Doctors usually start with the mildest option and move on to something stronger if it is not enough. Even so, not every treatment works for every person, which is why research into new options remains so important.
This is where clinical trials come in. Across the UK, researchers are testing new medicines and treatment approaches, looking for options that work faster, last longer or cause fewer side effects. People interested in taking part can look into ongoing psoriasis clinical trials happening at research centres around the country.
Being a participant in a clinical trial usually means more frequent check-ups with medical staff, access to treatments that are not yet widely available, and the chance to contribute to research that could help thousands of other people manage the condition in future. Trials are closely monitored for safety, and participants are given clear information about what to expect before they agree to take part.
For anyone living with psoriasis who feels their current treatment is not working well enough, exploring clinical trials for psoriasis can be a useful next step to discuss with a GP or dermatologist. As research continues, the hope is that people with psoriasis will have more effective and better tolerated treatment choices in the years ahead.
Anyone experiencing symptoms of psoriasis for the first time should speak to their GP, who can confirm a diagnosis and discuss the full range of treatment options available.
This article is intended for general information only and does not constitute medical advice. If you have symptoms of psoriasis or any other health concern, please speak to your GP or a qualified healthcare professional.
